HYPOTHALAMIC OBESITY
Clinical trials for HYPOTHALAMIC OBESITY explained in plain language.
Never miss a new study
Get alerted when new HYPOTHALAMIC OBESITY trials appear
Sign up with your email to follow new studies for HYPOTHALAMIC OBESITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug targets obesity caused by brain damage
Disease control OngoingThis study tests a daily injection called setmelanotide to help people aged 4 and older who gained weight after a brain injury (hypothalamic obesity). The goal is to see if it reduces body weight, hunger, and improves quality of life over 52 weeks. Half of the 143 participants wi…
Matched conditions: HYPOTHALAMIC OBESITY
Phase: PHASE3 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for hypothalamic obesity: Long-Term drug trial launches
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety and effects of a drug called bivamelagon in people with hypothalamic obesity, a condition where the brain's hunger control is damaged. About 25 participants who completed a previous study will take the drug for up to 2 years. Researchers w…
Matched conditions: HYPOTHALAMIC OBESITY
Phase: PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC